Crystal of (23S)-1alpha-hydroxy-27-nor-25-methyl enevitamin D3-26,23-lactone and process for producing the same

Details for Australian Patent Application No. 2004207720 (hide)

Owner Teijin Pharma Limited

Inventors Manabe, Kenji; Takenouchi, Kazuya

Agent Davies Collison Cave

Pub. Number AU-A-2004207720

PCT Pub. Number WO2004/067526

Priority 2003-023365 31.01.03 JP

Filing date 29 January 2004

Wipo publication date 12 August 2004

International Classifications

C07D 307/58 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61P 019/00 Drugs for skeletal disorders

A61P 019/08 Drugs for skeletal disorders

A61P 019/10 Drugs for skeletal disorders

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 035/00 Antineoplastic agents

A61P 043/00 Drugs for specific purposes, not provided for in groups

B01D 009/02 Crystallisation

A61K 031/593

A61P 003/10 Drugs for disorders of the metabolism

A61P 003/14 Drugs for disorders of the metabolism

A61P 005/20 Drugs for disorders of the endocrine system

A61P 009/12 Drugs for disorders of the cardiovascular system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 017/06 Drugs for dermatological disorders

A61P 017/10 Drugs for dermatological disorders

A61P 017/14 Drugs for dermatological disorders

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/067526 Priority application(s): WO2004/067526

10 November 2005 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Sep 2005

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004207726-Oligosaccharide derivative

2004207719-Vitamin D3 lactone derivative